Diabetes stories

Australians with diabetes can now monitor glucose levels and receive alerts directly on their Apple Watch through new Dexcom G7 integration.

Dexcom's latest innovation, the ONE+, is set to transform diabetes management in Australia by offering real-time glucose monitoring and alerts for Type 2 diabetes.

Salesforce has rolled out Agentforce 2dx, a cutting-edge digital labour platform that integrates AI agents into business workflows for enhanced efficiency.

AI agents are set to transform daily life across sectors, optimising everything from smart homes to personalised shopping, according to Raphael Allstadt.

Dexcom has launched its Dexcom ONE+ continuous glucose monitoring system in Australia, enhancing glucose management for those with Type 2 diabetes.

The peptide Active Pharmaceutical Ingredient market is poised for significant growth, driven by demand for targeted therapies and advances in synthesis technology.

The healthcare sector is on the brink of transformation as experts predict the AI market could reach USD $17.2 billion by 2032, revolutionising patient care.

Iktos and Cube Biotech have partnered to leverage AI-driven drug discovery and advanced protein technology, targeting the Amylin Receptor for cardiometabolic disorders.

Australians travelling this holiday season can now manage their health with new features on the my health app, enhancing access to vital information.

A report reveals ongoing financial strain for Australians and New Zealanders, with rising living costs leaving nearly half feeling worse off than last year.

Ransomware tactics have evolved significantly, prompting Australian organisations to focus on midgame detection to counteract increasing cyber threats.

The gamified healthcare app market is predicted to soar to USD $31 billion by 2034, bolstered by rising chronic disease incidences.

Dexcom has rolled out its advanced Dexcom G7 glucose monitoring system in Australia, featuring rapid sensor activation, no fingerpricks, and improved connectivity.

Apple introduces health features for the Apple Watch and AirPods Pro 2, targeting sleep apnoea and hearing issues, expanding its health-tech footprint.

Capgemini's new report reveals a six-fold surge in connected health solutions in pharma and biotech since 2021, with organisations expecting 20% of revenue from these services within five years.

Zurich and UTS have developed AI models to streamline life insurance underwriting, significantly cutting the time for decisions on mental health disclosures from 22 days to instant approvals.

Irish women are at the helm of transforming healthcare through digital innovation, improving patient outcomes, and shaping the future of health-tech worldwide.

The sleep screening devices market is predicted to expand at a CAGR of 6.6% between 2023 and 2033, totalling around US$17.5 billion by 2033.

The digital health market is expected to be worth US$224.24 billion in 2022 and is likely to grow at a CAGR of 27.7% to reach USD $2.586 trillion by 2032.

The global market for digital wound measurement devices is likely to reach US$3,293.3 million by 2033, expanding at 3.8% CAGR over the next ten years.